About this document
Iloprost Effects on ADMA and Serotonin in PAOD by reclinpharma is a document available to read on EtoBox.
The study investigates the effects of a one-week treatment with iloprost on plasma asymmetric dimethylarginine (ADMA) and serotonin levels in patients with critical limb ischemia due to peripheral arterial occlusive disease. Results showed a significant decrease in plasma ADMA and an increase in platelet serotonin, alongside clinical improvements in the patients. The findings suggest that iloprost treatment may positively influence markers of endothelial dysfunction and atherosclerosis in this patient popul
- Author
- reclinpharma
- Language
- EN